Optilume® BPH Catheter System

DEVICE2 trials

Sponsors

Urotronic Inc., Centre hospitalier de l'Université de Montréal (CHUM)

Conditions

Benign Prostatic HyperplasiaBenign Prostatic Hyperplasia (BPH)Lower Urinary Track Symptoms

Unknown Phase

Safety and Effectiveness of the Optilume® BPH Catheter System in a Post-Market Study

RecruitingNCT06312722

Urotronic Inc.Benign Prostatic Hyperplasia

Start: 2024-02-07End: 2031-02-07Target: 92Updated: 2026-07-10

Evaluation of the Optilume BPH Catheter System and the Rezum Water Vapor Therapy in Treating Benign Prostatic Hyperplasia

RecruitingNCT06769997

Centre hospitalier de l'Université de Montréal (CHUM)Benign Prostatic Hyperplasia (BPH), Lower Urinary Track Symptoms

Start: 2025-05-09End: 2027-01-31Target: 100Updated: 2025-07-17